Objective Corporation Limited - OCL.AX

OCL.AX Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
OCL.AX	-0.5	1.3	-0.5	3.2	33.5	33.0	3.2	158.0	1000.7	3202
S&P 500	0.5	-0.8	3.2	6.4	9.9	25.3	34.5	88.2	200.4	34278.1

Compare OCL.AX with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	OCL.AX
name	Objective Corporation Limited
price	16.51
changes percentage	-0.5422
change	-0.09
day low	16.09
day high	16.62
year high	18.55
year low	10.92
market cap	1572218292
price avg 50	16.658
price avg 200	14.26155
exchange	ASX
volume	18819
avg volume	48301
open	16.61
previous close	16.6
eps	0.32
pe	51.59
earnings announcement	2025-02-20T10:59:00.000+0000
shares outstanding	95228243
timestamp	2025-01-31 05:10:45

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 81.3%

Overall Quarterly Financial Health: 57.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
revenue	114804000	108919000	5.40
gross profit	107207000	96787000	10.77
gross profit ratio	0.93	0.89	5.09
research and development expenses	17046000	27208000	-37.35
operating expenses	70864000	75646000	-6.32
interest income	2696000	1445000	86.57
interest expense	657000	495000	32.73
ebitda	45010000	26078000	72.60
ebitdaratio	0.39	0.24	63.75
operating income	39039000	21141000	84.66
operating income ratio	0.34	0.19	75.19
net income	31330000	21087000	48.57
net income ratio	0.27	0.19	40.96
eps	0.33	0.22	50.00

Overall Score of Annual Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 115 million in 2024 from 109 million in 2023 representing a change of 5.4%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 107 million in 2024 from 97 million in 2023 representing a change of 10.77%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 71 million in 2024 from 76 million in 2023 representing a change of -6.32%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 45 million in 2024 from 26 million in 2023 representing a change of 72.6%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 39 million in 2024 from 21 million in 2023 representing a change of 84.66%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 31 million in 2024 from 21 million in 2023 representing a change of 48.57%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.33 in 2024 from 0.33 in 2023 representing a change of 50.0%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 17 million in 2024 from 27 million in 2023 representing a change of -37.35%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q2	Q/Q change %
0000000000
revenue	59717000	57783000	3.35
gross profit	55922000	50877000	9.92
gross profit ratio	0.94	0.88	6.36
research and development expenses	9837000	7209000	36.45
operating expenses	36854000	30858000	19.43
interest income	0	0	NaN
interest expense	320000	337000	-5.04
ebitda	17880000	23123000	-22.67
ebitdaratio	0.3	0.4	-25.18
operating income	19068000	20019000	-4.75
operating income ratio	0.32	0.35	-7.84
net income	14927000	16402999	-9.00
net income ratio	0.25	0.28	-11.95
eps	0.16	0.17	-5.88

Overall Score of Quarterly Income Statement

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 60 million in 2024Q4 from 58 million in 2024Q2 representing a change of 3.35%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 56 million in 2024Q4 from 51 million in 2024Q2 representing a change of 9.92%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 10 million in 2024Q4 from 7 million in 2024Q2 representing a change of 36.45%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 37 million in 2024Q4 from 31 million in 2024Q2 representing a change of 19.43%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 18 million in 2024Q4 from 23 million in 2024Q2 representing a change of -22.67%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 19 million in 2024Q4 from 20 million in 2024Q2 representing a change of -4.75%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 15 million in 2024Q4 from 16 million in 2024Q2 representing a change of -9.0%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.16 in 2024Q4 from 0.16 in 2024Q2 representing a change of -5.88%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
total assets	172898000	159985000	8.07
total liabilities	80597000	86436000	-6.76
total equity	92301000	73549000	25.50
cash and cash equivalents	95979000	72519000	32.35
short term investments	0	0	NaN
long term investments	8000	20000	-60.00
total current assets	105911000	99696000	6.23
total non current assets	66987000	60289000	11.11
total current liabilities	68144000	72010000	-5.37
total non current liabilities	12453000	14426000	-13.68
common stock	12385000	11722000	5.66
retained earnings	90597000	72119000	25.62
total debt	13448000	15917000	-15.51

Overall Score of Annual Balance Sheet

1.0 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 173 million in 2024 from 160 million in 2023 representing a change of 8.07%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 81 million in 2024 from 86 million in 2023 representing a change of -6.76%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 92 million in 2024 from 74 million in 2023 representing a change of 25.5%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 96 million in 2024 from 73 million in 2023 representing a change of 32.35%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 106 million in 2024 from 100 million in 2023 representing a change of 6.23%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 68 million in 2024 from 72 million in 2023 representing a change of -5.37%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 12 in 2024 from 12 in 2023 representing a change of 5.66%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 91 million in 2024 from 72 million in 2023 representing a change of 25.62%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 13 million in 2024 from 16 million in 2023 representing a change of -15.51%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q2	Q/Q change %
0000000000
total assets	172898000	145531000	18.80
total liabilities	80597000	68414000	17.81
total equity	92301000	77117000	19.69
cash and cash equivalents	95979000	67109000	43.02
short term investments	0	0	NaN
long term investments	8000	8000	0.00
total current assets	105911000	83074000	27.49
total non current assets	66987000	62457000	7.25
total current liabilities	68144000	55506000	22.77
total non current liabilities	12453000	12908000	-3.52
common stock	12385000	12279000	0.86
retained earnings	90597000	75695000	19.69
total debt	13448000	14671000	-8.34

Overall Score of Quarterly Balance Sheet

0.78 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 173 million in 2024Q4 from 146 million in 2024Q2 representing a change of 18.8%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 92 million in 2024Q4 from 77 million in 2024Q2 representing a change of 19.69%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 96 million in 2024Q4 from 67 million in 2024Q2 representing a change of 43.02%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 106 million in 2024Q4 from 83 million in 2024Q2 representing a change of 27.49%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 12 in 2024Q4 from 12 in 2024Q2 representing a change of 0.86%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 91 million in 2024Q4 from 76 million in 2024Q2 representing a change of 19.69%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 13 million in 2024Q4 from 15 million in 2024Q2 representing a change of -8.34%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 81 million in 2024Q4 from 68 million in 2024Q2 representing a change of 17.81%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 68 million in 2024Q4 from 56 million in 2024Q2 representing a change of 22.77%. This indicates a higher short-term debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
net change in cash	23460000	8725000	168.88
operating cash flow	55784000	23427000	138.12
free cash flow	40690000	22855000	78.04
capital expenditure	-15094000	-572000	-2538.81
depreciation and amortization	5978000	4937000	21.09
deferred income tax	0	-14124000	100.00
stock based compensation	2005000	600000	234.17
accounts payables	0	-713000	100.00
inventory	0	0	NaN
acquisitions net	-93000	-198000	53.03
investments in property plant and equipment	-1006000	-572000	-75.87
net cash used for investing activites	-15175000	-757000	-1904.62
debt repayment	0	0	NaN
common stock issued	761000	690000	10.29
common stock repurchased	-2582000	-1239000	-108.39
dividends paid	-12791000	-10389000	-23.12
net cash used provided by financing activities	-17155000	-14100000	-21.67
cash at end of period	95979000	72519000	32.35
accounts receivables	16202000	-2937000	651.65
cash at beginning of period	72519000	63794000	13.68

Overall Score of Annual Cashflow Statement

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 23 million in 2024 from 9 million in 2023 representing a change of 168.88%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 56 million in 2024 from 23 million in 2023 representing a change of 138.12%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 41 million in 2024 from 23 million in 2023 representing a change of 78.04%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -15 million in 2024 from -1 million in 2023 representing a change of -2538.81%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2024 from 1 million in 2023 representing a change of 100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2024 from -14 million in 2023 representing a change of 100.0%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 2 million in 2024 from 1 million in 2023 representing a change of 234.17%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 16 in 2024 from -3 million in 2023 representing a change of 651.65%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -13 million in 2024 from -10 million in 2023 representing a change of -23.12%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q2	Q/Q change %
0000000000
operating cash flow	39510000	16274000	142.78
free cash flow	38743000	8987000	331.10
capital expenditure	-767000	-7287000	89.47
depreciation and amortization	2874000	3104000	-7.41
deferred income tax	0	0	NaN
stock based compensation	2005000	0	NaN
accounts receivables	16202000	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	-93000	100.00
investments in property plant and equipment	-767000	-7287000	89.47
net cash used for investing activites	-7807000	-7368000	-5.96
debt repayment	0	-1226000	100.00
common stock issued	0	0	NaN
common stock repurchased	-1494000	-1088000	-37.32
dividends paid	-9000	-12782000	99.93
net cash used provided by financing activities	-2683000	-14472000	81.46
net change in cash	28870000	-5410000	633.64
cash at end of period	95979000	67109000	43.02
cash at beginning of period	67109000	72519000	-7.46

Overall Score of Quarterly Cashflow Statement

0.57 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 29 million in 2024Q4 from -5 million in 2024Q2 representing a change of 633.64%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 40 million in 2024Q4 from 16 million in 2024Q2 representing a change of 142.78%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 39 million in 2024Q4 from 9 million in 2024Q2 representing a change of 331.1%. This indicates an increase in cash generated after accounting for capital expenditures.

  Dividends Paid: Dividends Paid increased to 0 million in 2024Q4 from -13 million in 2024Q2 representing a change of 99.93%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -1 million in 2024Q4 from -7 million in 2024Q2 representing a change of 89.47%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 2 million in 2024Q4 from 0 million in 2024Q2 representing a change of nan%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 16 in 2024Q4 from 0 million in 2024Q2 representing a change of nan%. This suggests that the company is less capable of collecting payments from its customers.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-06-30	2023-06-30	Y/Y change %
FY
calendar year	2024	2023	NaN
revenue per share	1.21	1.15	5.20
net income per share	0.33	0.22	48.28
operating cash flow per share	0.59	0.25	137.65
free cash flow per share	0.43	0.24	77.68
cash per share	1.01	0.76	32.09
book value per share	0.97	0.77	25.25
tangible book value per share	0.41	-0.07	683.28
shareholders equity per share	0.97	0.77	25.25
interest debt per share	0.15	0.17	-14.23
market cap	1119367168.08	1308102507.27	-14.43
enterprise value	1036836168.08	1251500507.27	-17.15
pe ratio	35.73	62.03	-42.40
price to sales ratio	9.75	12.01	-18.81
pocfratio	20.07	55.84	-64.06
pfcf ratio	27.51	57.23	-51.94
pb ratio	12.13	17.79	-31.81
ptb ratio	12.13	17.79	-31.81
ev to sales	9.03	11.49	-21.40
enterprise value over ebitda	23.04	47.99	-52.00
ev to operating cash flow	18.59	53.42	-65.21
ev to free cash flow	25.48	54.76	-53.47
earnings yield	0.03	0.02	73.63
free cash flow yield	0.04	0.02	108.05
debt to equity	0.15	0.22	-32.68
debt to assets	0.08	0.1	-21.82
net debt to ebitda	-1.83	-2.17	15.52
current ratio	1.55	1.38	12.26
interest coverage	59.42	42.71	39.13
income quality	1.78	1.11	60.27
dividend yield	0.01	0.01	43.88
payout ratio	0.41	0.49	-17.13
sales general and administrative to revenue	0.1	0.1	2.17
research and ddevelopement to revenue	0.15	0.25	-40.56
intangibles to total assets	0.31	0.5	-38.38
capex to operating cash flow	0.27	0.02	1008.19
capex to revenue	0.13	0.01	2403.54
capex to depreciation	2.52	0.12	2079.29
stock based compensation to revenue	0.02	0.01	217.04
graham number	2.68	1.97	36.28
roic	0.29	0.53	-44.02
return on tangible assets	0.26	0.26	-0.80
graham net net	0.21	0.03	521.30
working capital	37767000	27686000	36.41
tangible asset value	38894000	-6655000	684.43
net current asset value	25314000	13260000	90.90
invested capital	104740000	124486000	-15.86
average receivables	14265000	21271000	-32.94
average payables	7145500	7034500	1.58
average inventory	0.5	0.5	0.00
days sales outstanding	18.3	76.32	-76.03
days payables outstanding	340.74	216.59	57.32
days of inventory on hand	0	0.0	-100.00
receivables turnover	19.95	4.78	317.13
payables turnover	1.07	1.69	-36.44
inventory turnover	0	12132000	-100.00
roe	0.34	0.29	18.39
capex per share	0.16	0.01	2533.61

• Positive

  ROE: Return on Equity (ROE) increased to 0.34 on 2024-06-30 from 0.29 on 2023-06-30, representing a change of 18.39%. Suggesting the company has been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 1.55 on 2024-06-30 from 1.38 on 2023-06-30, representing a change of 12.26%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.15 on 2024-06-30 from 0.22 on 2023-06-30, representing a change of -32.68%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 35.73 on 2024-06-30 from 62.03 on 2023-06-30, representing a change of -42.40%. Indicating a decrease in the relative valuation of the company's stock.

• Quarterly Financial Ratios

	2024-06-30 Q4	2023-12-31 Q2	Q/Q change %
OCL.AX
calendar year	2024	2024	NaN
revenue per share	0.63	0.61	3.39
net income per share	0.16	0.17	-8.96
operating cash flow per share	0.42	0.17	142.89
free cash flow per share	0.41	0.09	331.30
cash per share	1.01	0.7	43.09
book value per share	0.97	0.81	19.75
tangible book value per share	0.41	0.31	30.21
shareholders equity per share	0.97	0.81	19.75
interest debt per share	0.14	0.16	-8.22
market cap	1119095476.8	1191018503.16	-6.04
enterprise value	1036564476.8	1138580503.16	-8.96
pe ratio	18.74	18.15	3.25
price to sales ratio	18.74	20.61	-9.08
pocfratio	28.32	73.19	-61.30
pfcf ratio	28.89	132.53	-78.20
pb ratio	12.12	15.44	-21.50
ptb ratio	12.12	15.44	-21.50
ev to sales	17.36	19.7	-11.91
enterprise value over ebitda	57.97	49.24	17.74
ev to operating cash flow	26.24	69.96	-62.50
ev to free cash flow	26.75	126.69	-78.88
earnings yield	0.01	0.01	-3.15
free cash flow yield	0.03	0.01	358.81
debt to equity	0.15	0.19	-23.42
debt to assets	0.08	0.1	-22.85
net debt to ebitda	-4.62	-2.27	-103.54
current ratio	1.55	1.5	3.85
interest coverage	59.59	59.4	0.31
income quality	2.65	0.99	166.79
dividend yield	0.0	0.01	-99.93
payout ratio	0.0	0.78	-99.92
sales general and administrative to revenue	0.1	0.1	-2.63
research and ddevelopement to revenue	0.16	0.12	32.04
intangibles to total assets	0.31	0.32	-4.82
capex to operating cash flow	0.02	0.45	-95.66
capex to revenue	0.01	0.13	-89.82
capex to depreciation	0.27	2.35	-88.63
stock based compensation to revenue	0.03	0	NaN
graham number	1.85	1.77	4.41
roic	0.14	0.18	-24.20
return on tangible assets	0.12	0.17	-25.14
graham net net	0.21	0.08	160.78
working capital	37767000	27568000	37.00
tangible asset value	38894000	29885000	30.15
net current asset value	25314000	14660000	72.67
invested capital	104740000	89427000	17.12
average receivables	8785500	17295500	-49.20
average payables	7407500	7461000	-0.72
average inventory	0	0.5	-100.00
days sales outstanding	8.67	18.4	-52.87
days payables outstanding	168.19	100.65	67.11
days of inventory on hand	0	0	NaN
receivables turnover	10.38	4.89	112.19
payables turnover	0.54	0.89	-40.16
inventory turnover	0	0	NaN
roe	0.16	0.21	-23.97
capex per share	0.01	0.08	-89.47

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.16 on 2024-06-30 Q4 from 0.21 on 2023-12-31 Q2, representing a change of -23.97%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 18.74 on 2024-06-30 Q4 from 18.15 on 2023-12-31 Q2, representing a change of 3.25%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.55 on 2024-06-30 Q4 from 1.50 on 2023-12-31 Q2, representing a change of 3.85%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.15 on 2024-06-30 Q4 from 0.19 on 2023-12-31 Q2, representing a change of -23.42%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 15.31 which is lower than current price 16.51, indicates the company may be overvalued.